Non-small Cell Lung Cancer Study US75 (Z-PACT)

This study will evaluate the effects of an investigational drug in combination with chemotherapy in patients with stage IIIB/IV non-small cell lung cancer. This study will measure the effects of this combination on progression of lung cancer, cancer response to treatments, and development of cancer-related bone lesions.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Non Small Cell Lung Carcinoma Bronchial Neoplasms Carcinoma, Bronchogenic Carcinoma, Non-Small-Cell Lung Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Clinical Research Consultants, Hoover, Alabama, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Male or Female patients at least of 18 years old
Patients with diagnosed non-small cell lung cancer that cannot be treated by surgery
Women must not be pregnant or attempting to become pregnant
Able and willing to sign informed consent

Exclusion criteria

Patients with cancer that has spread to the bone
Patients with cancer that has spread to the brain who are receiving treatment
Patients with kidney disease
Patients treated with other investigational drugs

Treatment and study plan

Zoledronic acid

Drug

Taxotere

Drug

carboplatin

Drug

Sponsors and collaborators

Lead sponsor

Novartis Pharmaceuticals

Industry

Registry information

Acronym: ZPACT

Important dates

Study start: 2004
Primary completion: 2007
Study completion: 2007
First posted: Jul 1, 2004
Registry last updated: Sep 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed